-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ENKQUUuWQToTfNAD2g9kLiWypB33/CdlBQM0FEzQzoB9ubTukgx/v/xxB0hMrtHo /jX5CwXCW4LW9mSMlczmmQ== 0001491877-10-000002.txt : 20100519 0001491877-10-000002.hdr.sgml : 20100519 20100519144434 ACCESSION NUMBER: 0001491877-10-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100517 FILED AS OF DATE: 20100519 DATE AS OF CHANGE: 20100519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kessler Paul D. CENTRAL INDEX KEY: 0001428524 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-04829 FILM NUMBER: 10844972 MAIL ADDRESS: STREET 1: C/O NABI BIOPHARMACEUTICALS STREET 2: 12276 WILKINS AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20852 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NABI BIOPHARMACEUTICALS CENTRAL INDEX KEY: 0000072444 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 591212264 STATE OF INCORPORATION: DE FISCAL YEAR END: 1225 BUSINESS ADDRESS: STREET 1: 5800 PARK OF COMMERCE BLVD N W STREET 2: STE 322 CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 5619895800 MAIL ADDRESS: STREET 1: 5800 PARK OF COMMERCE BLVD NW STREET 2: STE 322 CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: NABI /DE/ DATE OF NAME CHANGE: 19960405 FORMER COMPANY: FORMER CONFORMED NAME: NORTH AMERICAN BIOLOGICALS INC DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-05-17 0000072444 NABI BIOPHARMACEUTICALS NABI 0001428524 Kessler Paul D. C/O NABI BIOPHARMACEUTICALS 12276 WILKINS AVE ROCKVILLE MD 20852 0 1 0 0 SVP Clinical, Med. & Reg.; CMO Common Stock 2010-05-17 4 S 0 300 5.68 D 112952 D Common Stock 2010-05-17 4 S 0 50 5.685 D 112902 D Common Stock 2010-05-17 4 S 0 850 5.69 D 112052 D Common Stock 2010-05-17 4 S 0 1000 5.695 D 111052 D Common Stock 2010-05-17 4 S 0 3205 5.70 D 107847 D Common Stock 2010-05-17 4 S 0 700 5.705 D 107147 D Common Stock 2010-05-17 4 S 0 3592 5.71 D 103555 D Common Stock 2010-05-17 4 S 0 100 5.715 D 103455 D Common Stock 2010-05-17 4 S 0 1900 5.72 D 101555 D Common Stock 2010-05-17 4 S 0 100 5.725 D 101455 D Common Stock 2010-05-17 4 S 0 1400 5.73 D 100055 D Common Stock 2010-05-17 4 S 0 1003 5.74 D 99052 D Common Stock 2010-05-17 4 S 0 600 5.75 D 98452 D Common Stock 2010-05-17 4 S 0 200 5.76 D 98252 D The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. James E. Dawson, as attorney-in-fact 2010-05-19 -----END PRIVACY-ENHANCED MESSAGE-----